交易 ACADIA Pharmaceuticals Inc - ACAD 差價合約
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson''s disease psychosis; Trofinetide, a novel synthetic analog for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor for treating cognition and schizophrenia. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.最新股票文章
2026 美股高位風險解析：納斯達克與標普 500 AI 估值架構拆解
差價合約（CFD）風險預警
差價合約（CFD）是複雜的金融工具，由於槓桿作用，存在快速虧損資金的高風險。數據顯示，78.48% 的零售投資者帳戶在與該提供商交易差價合約時出現虧損 。您應該仔細考慮是否了解差價合約的運作機制，以及您是否有能力承擔資金流失的高風險。
08:07, 11 6月 2026
AI供應鏈股解析：從基礎設施到個股風險的全景評估
⚠️ 差價合約（CFD）風險預警
差價合約（CFD）是複雜的金融工具，由於槓桿作用，存在快速虧損資金的高風險。數據顯示，78.48% 的零售投資者帳戶在與該提供商交易差價合約時出現虧損 。您應該仔細考慮是否了解差價合約的運作機制，以及您是否有能力承擔資金流失的高風險。
07:34, 11 6月 2026
港股成交放量與外資流入：中國經濟復甦如何影響恒生指數資金結構
2026年港股成交創半年新高，南向與北向資金雙雙放量。本文從資金結構、估值傳導、衍生品市場與板塊分化四個維度，拆解中國經濟復甦對恒生指數的影響。
14:06, 1 6月 2026
收息股：股息率分布、選股風險框架與高息ETF配置分析
2026年港股收息股與高息ETF的股息率結構、派息可持續性風險、估值環境及行業分散配置邏輯，涵蓋銀行股、REITs、公用事業及能源板塊的風險收益特徵分析
08:35, 27 3月 2026
評級和評論
評級和評論
